期刊文献+

乳腺癌外科治疗相关问题的认识与思考 被引量:5

原文传递
导出
摘要 乳腺癌的治疗已经从20世纪60年代的单一解剖生物学模式转化到社会.心理.生物学模式,治疗模式更趋于人性化,其突出表现在保留乳房手术(breast-conserving surgery,BCS)模式和前哨淋巴结活检(sentinel lymph node biopsy,SLNB)技术的开展、成熟及应用方面。以最小的有效性治疗达到最佳的临床疗效,已经成为医师和患者所共同追求的最高境界,而临床实践中如何把握尺度实现这一理想的境界,是我们应该不断思考的问题。
作者 左文述 杨莉
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2014年第5期394-397,共4页 Chinese Journal of Oncology
关键词 乳腺肿瘤 治疗 外科手术 前哨淋巴结活组织检查 Breast neoplasms Therapy Surgical procedures, operative Sentinel lymph node biopsy
  • 相关文献

参考文献10

二级参考文献144

共引文献214

同被引文献50

  • 1汪敏.早期乳腺癌保乳手术及改良根治术的临床疗效及生活质量的比较[J].实用癌症杂志,2014,29(3):321-323. 被引量:56
  • 2赵文生,黄安中,彭上清,刘景田,李成伟.保乳手术与改良根治术治疗早期乳腺癌的疗效对比[J].中国老年学杂志,2014,34(11):3005-3006. 被引量:69
  • 3Lu WL, Li HX, Qian BY, et al. The Clinical Characteristics and Prognosis of Chinese Early Stage Breast Cancer Patients: A Retrospective Study[J]. Breast Journal, 2010, 16(3):331-333.
  • 4Bruno C, Bernard A, Mario C, et al. Extended Benefit from Sequential Administration of Docetaxel after Standard Fluorouracil, Epirubicin, and Cyclophosphamide Regimen for Node-Positive Breast Cancer: The 8-Year Follow-Up Results of the UNICANCER-PACS01 Trial[J]. Oncologist, 2012, 17(7):900-909.
  • 5Teshome M, Hunt KK. Neoadjuvant Therapy in the Treatment of Breast Cancer[J]. Surgical Oncology Clinics of North America, 2014, 23(3):505-523.
  • 6Rudat V, Alaradi AA, Mohamed A, et al. Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: a dosimetric comparison[J]. Radiation Oncology, 2011, 6(1):23-30.
  • 7Chia SK, Ac. W. With maturity comes confidence: EBCTCG tamoxifen update[J]. Lancet, 2011, 378(9793):747-749.
  • 8Regan MM, Neven P, Giobbie-Hurder A, et al. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up[J]. Lancet Oncology, 2011, 12(12):1101-1108.
  • 9Ellis MJ. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype ACOSOG Z1031[J]. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology, 2011, 29(17): 2342-2349.
  • 10Schneeweiss A. Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)[J]. Annals of Oncology, 2013, 24(9):2278-2284.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部